XNAS · Healthcare · Biotechnology
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-05 | Q2 2026 | 0.01 | 0.00 | -100.00% | $263.7M | ❌ Miss | +13.92% | +35.32% | — |
| 2026-05-07 | Q1 2026 | -0.02 | 0.00 | +100.00% | $216.2M | ✅ Beat | -10.94% | -23.14% | -16.89% |
| 2026-02-26 |
| Q4 2025 |
| 0.07 |
| 0.28 |
| +300.00% |
| $292.9M |
| ✅ Beat |
| +16.84% |
| -0.10% |
| -11.90% |
| 2025-11-05 | Q3 2025 | -0.11 | 0.08 | +172.73% | $216.8M | ✅ Beat | — | — | — |
| 2025-08-12 | Q2 2025 | — | -7.97 | — | $181.4M | — | +3.20% | +13.77% | +5.39% |
Showing last 5 quarters.